2014-2015 Personalized medicine
The Theme of the Year was introduced in 2012 to focus the attention on a certain topic in various publications and in sessions in the Annual Congress. Articles on the topic appear in Hematopics as well as editorials in Haematologica. Selected Scientific Working Groups are asked to write on the topic from their specific field of interest.
In 2014-2015, the spotlight was on the multifaceted issue of Personalized Medicine.
Personalized Medicine concerns almost everybody: patients, doctors, policy makers and researchers. It is important in policy debates about the cost of healthcare and medicine, health inequality, research regulations, and research funding. The stratification of diseases will provide challenges to the education and training of hematologists, and will change the way we diagnose and treat them.
EHA has already paid quite some attention to the topic of Personalized Medicine in the past few years. The topic was covered in EHA’s previous congress programs. The topic was also covered in several articles in Haematologica. Moreover, Personalized Medicine is an important part of the work that EHA European Affairs is undertaking since Brussels see it as an important topic that is consequential for the way they regulate research, allocate research funds, and help curb healthcare spending.